Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted 2,4 diamino-quinoline as new medicament for fibrosis, autophagy and cathepsins B (CTSB), L (CTSL) and D (CTSD) related diseases

Substituted 2,4 diamino-quinoline as new medicament for fibrosis, autophagy and cathepsins B (CTSB), L (CTSL) and D (CTSD) related diseases

US Patent 11261189 · Granted Mar 1, 2022

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted 2,4 diamino-quinoline as new anticancer agents2020
Substituted 2,4 diamino-quinoline as new anticancer agents2020
Substituted 2,4 diamino-quinoline as new anticancer agents2020
Substituted 2,4 diamino-quinoline as new anticancer agents2020
Substituted 2, 4-diamino-quinoline derivatives for use in the treatment of proli2020
Substituted 2, 4-diamino-quinoline derivatives for use in the treatment of proli2020
Substituted 2, 4-diamino-quinoline derivatives for use in the treatment of proli2020
Substituted 2, 4-diamino-quinoline derivatives for use in the treatment of proli2020
Quinolines derivatives as novel anticancer agents2019
Quinolines derivatives as novel anticancer agents2019
Quinolines derivatives as novel anticancer agents2019
Quinolines derivatives as novel anticancer agents2019